At Lucile Packard Children’s Hospital, our Pediatric Surgical Oncology Program provides expert, compassionate care for children and adolescents with solid tumors, including neuroblastoma, Wilms tumors, rhabdomyosarcoma, germ cell tumors, and other rare malignancies. Our team of pediatric surgeons collaborates closely with pediatric oncologists, radiologists, pathologists, and radiation oncologists to develop personalized treatment plans tailored to each child’s unique needs.

Stanford is home to some of the world’s leading experts in pediatric cancer research and treatment. Dr. Hiroyuki Shimada, a globally recognized leader in neuroblastoma pathology, is a close collaborator. His expertise in tumor classification and risk stratification helps define best treatment strategies for neuroblastoma, ensuring that each child receives the most appropriate and effective care. Active groundbreaking basic research is led by Dr. Bill Chiu, whose laboratory is dedicated to understanding the mechanisms of pediatric solid tumors and developing innovative therapies to precisely target their causes. Dr. Chiu’s lab pursues several key goals to advance the treatment of childhood solid tumors on multiple fronts.

As a member of the Children’s Oncology Group (COG) and the Pediatric Surgical Oncology Research Collaborative, our program offers access to cutting-edge surgical techniques, innovative clinical trials, and the latest evidence-based treatment protocols. We prioritize minimally invasive and advanced surgical approaches whenever possible to enhance outcomes and recovery.

Through a multidisciplinary, patient- and family-centered approach, we ensure that every child receives the highest level of care in a supportive environment. From diagnosis to long-term survivorship, our team is committed to delivering the best possible outcomes for children and their families.